DigestRedComo funciona
Red
/
Empresas
Cu
No verificado

Curium

Sobre qué escribimos

Anuncios brevesFarmacéuticaGestión empresarial/Administración de EmpresasMedicina Salud Bienestar

14 Comunicados de prensa

Ver todos los comunicados de prensa
07/01/2026
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
22/12/2025
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
20/11/2025
Farmacéutica
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
19/11/2025
Farmacéutica
Gestión empresarial/Administración de Empresas
Medicina Salud Bienestar
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
17/11/2025
Farmacéutica
Anuncios breves
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
14/10/2025
Farmacéutica
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
21/05/2025
Farmacéutica
Gestión empresarial/Administración de Empresas
Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
12/05/2025
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
10/04/2025
Farmacéutica
Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
27/03/2025
Farmacéutica
Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0